← SynDRA
TYROSINE
SynDRA canonical compound SYN0002607 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | TAT | TH | YARS | YARS2 |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CA5B
- CA1
- CA2
- CA5A
- CA6
- PGR
- HTR2B
- KCNH2
- KDR
- MAOA
- MPO
- OPRM1
- PDE3A
- PDE4A
- ACHE
- HRH3
- PTGS1
- SLC16A10
- SLC6A2
- SLC6A3
- SLC6A4
- TAS2R14
- TBXA2R
- HTR1A
- DRD3
- F2
- ESR1
- ADRA1A
- ADRA2A
- AR
- CA12
- CA14
- CA3
- CA4
- CA7
- CA9
- CHRM1
- CHRM2
- CSK
- CYP46A1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Cross-references
Synonyms
- TPN
- L-Tyrosine
- (S)-Tyrosine
- Tirosina
- L-tyrosine
- FEMA NO. 3736
- NSC-82624
- Levodopa impurity, l-tyrosine-
- Levodopa related compound l-tyrosine
- DTY
- Rxosine
- Tyr
- Tyrosinum
- Tirosina [Spanish]
- Tyrosine Power
- Tyrosinum [Latin]
- Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs
- L-Tyrosin
- L-Tyrosine hydrochloride
- Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide
- P-Tyrosine
- TYR NH3+ COOH
- Tyrosine (VAN)
- Tyrosine [USAN:INN]
- Free-Form L-Tyrosine
- H-Tyr-OH
- L-Tyrosine (9CI)
- L-Tyrosine (JAN)
- L-Tyrosine, homopolymer
- L-Tyrosine, monomer
- L-p-Tyrosine
- Melanin synthesized from Tyr substrate catalyzed by tyrosinase, brominated with N-bromosuccinimide
- Tyrosine (USP/INN)
- Beta-(p-Hydroxyphenyl)alanine
- Melanin synthesized from Tyr substrate catalyzed by tyrosinase for 6 hrs, oxidized with hydrogen peroxide, <3 kd fraction
- Tyrosine, L-(8CI)
- DD69927C-C6A8-4BC6-8E9A-0AB423B176E7
- L-(-)-Tyrosine
Reported adverse events
- Electrolyte imbalance
- Hypersensitivity
- Infection
- Pulmonary embolism
- Refeeding syndrome
- Alkalosis
- Extravasation
- Glycosuria
- Local reaction
- Metabolic acidosis
- Death
- Sepsis
Look up TYROSINE in the interactive SynDRA portal →